tiprankstipranks
Finch Therapeutics Group (FNCH)
NASDAQ:FNCH
US Market

Finch Therapeutics Group (FNCH) Cash flow

50 Followers

Finch Therapeutics Group Cash Flow

FNCH's free cash flow for Q1 2024 was $-4.36M. For the 2024 fiscal year, FNCH's free cash flow was decreased by $6.02M and operating cash flow was $-4.36M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -23.00M$ -74.85M$ -67.13M$ -31.33M$ -17.32M
Investing Cash Flow
$ 6.00K$ -2.18M$ -15.92M$ -2.63M$ -973.00K
Financing Cash Flow
$ -16.16M$ 14.87M$ 119.11M$ 91.47M$ 53.30M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 98.49M$ 73.81M$ 135.97M$ 99.91M$ 42.40M
Income Tax Paid Supplemental Data
-----
Interest Paid Supplemental Data
$ 202.00K$ 741.00K$ 9.00K$ 11.00K$ 8.00K
Issuance Of Capital Stock
--$ 118.58M$ 90.00M$ 48.67M
Issuance Of Debt
$ -15.00M$ 14.74M-$ 1.81M$ 4.80M
Repayment Of Debt
$ -15.00M--$ -47.00K$ -71.00K
Free Cash Flow
$ -23.00M$ -77.03M$ -83.05M$ -33.96M$ -18.32M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

Finch Therapeutics Group Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis